The PDX1 gene, also known as the pancreatic and duodenal homeobox 1 gene, is a crucial transcription factor that plays a vital role in pancreatic development and function. Located on human chromosome 13, this gene encodes a protein belonging to the homeobox transcription factor family, whose members are essential for regulating embryonic development and cell differentiation. PDX1 is particularly important for the formation of the pancreas during embryonic development, guiding the proliferation and differentiation of pancreatic progenitor cells into endocrine and exocrine cell lineages. In mature pancreatic β-cells, PDX1 continues to play a crucial role, regulating the expression of key genes involved in insulin production and glucose homeostasis. Mutations or functional abnormalities in PDX1 are associated with various forms of diabetes, including maturity-onset diabetes of the young type 4 (MODY4). The gene''s ability to regulate insulin secretion and β-cell survival makes it a focus of diabetes research and regenerative medicine.
The hPDX1 adenovirus is a recombinant adenoviral vector designed to deliver the human PDX1 gene into target cells, making it a powerful tool in molecular biology and gene therapy. This viral vector utilizes the natural efficiency of adenoviruses in infecting a wide range of cell types, promoting high levels of transgene expression without integration into the host genome. In research, the hPDX1 adenovirus is widely used to overexpress PDX1 in vitro or in animal models to study pancreatic development, β-cell differentiation, and diabetes mechanisms. Therapeutically, it holds promise for regenerating functional β-cells in diabetic patients by directly reprogramming non-β-cells into insulin-producing cells or enhancing the survival and function of existing β-cells. Furthermore, it aids in the creation of disease models for drug screening and in elucidating pathways involved in islet cell neogenesis.
Since diabetes is caused by an absolute or relative deficiency of insulin secretion from pancreatic β cells, efforts have been devoted to finding methods to effectively generate replacement β cells. So far, insulin-secreting cells have been generated from various differentiated cell types in the pancreas, such as acinar cells and α cells, by inducing specific transcription factors, such as PDX1 and MAFA. However, how to effectively generate replacement β cells to establish future regenerative therapies for diabetes remains a challenge. Here, researchers demonstrated that exogenously expressed PDX1 activated STAT3 in α cells in vitro, while α cells expressing STAT3-deficient PDX1 in vivo effectively induced α-to-β reprogramming, with the emergence of insulin-secreting cells derived from α cells, whose glucagon expression was suppressed. Depletion of β cells by administration of a degenerative toxin significantly increased the number of α-cell-derived insulin-secreting cells, while inhibition of STAT3 resulted in no increase in β-cell neogenesis after β-cell depletion. Therefore, STAT3 regulation and β-cell depletion non-additively enhanced PDX1-induced α-β reprogramming, which may help establish cell therapies for the treatment of diabetes.
STAT3 has been shown to be activated in pancreatic acinar cells that ectopically express Pdx1. To investigate whether STAT3 is activated in both pancreatic α cells and acinar cells, αTC1 cells were infected with an adenoviral vector expressing Pdx1 (Ad-Pdx1). Immunoblotting of STAT3 phosphorylated at Tyr705 (pSTAT3) showed that pSTAT3 levels were significantly increased in αTC1 cells infected with Ad-Pdx1 compared with control αTC1 cells infected with adenovirus expressing green fluorescent protein (GFP) (Ad-GFP) 72 h after infection (Figure 1A, B). In addition, immunocytochemical staining clearly detected pSTAT3 protein in Ad-Pdx1-infected αTC1 cells, with high expression of PDX1, while the number of pSTAT3-positive cells was low in cells with weak PDX1 expression and control cells infected with Ad-GFP (Figure 1C). When αTC1 cells were infected with an adenoviral vector expressing Mafa (Ad-Mafa), another β-cell-specific transcription factor, exogenously expressed Mafa did not activate STAT3. This is in contrast to previous findings in mPAC cells, which exhibit pancreatic progenitor-like characteristics. Taken together, these findings suggest that Pdx1 activates STAT3 not only in acinar cells but also in α cells.
Figure 1. Ectopic expression of Pdx1 induces STAT3 activation in α cells. (Wakabayashi Y, et al., 2022)
Customer Reviews
High titer
The hPDX1 adenovirus from Creative Biogene worked flawlessly in our studies on pancreatic beta-cell differentiation. High titer, great purity, and reliable expression. Highly recommended for diabetes research!
Write a Review